Taysha Gene Therapies Inc. (TSHA)
NASDAQ · Healthcare
Taysha Gene Therapies Inc. Long Term Debt 2022–2025
Taysha Gene Therapies Inc. annual long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Taysha Gene Therapies Inc. long term debt as of December 31, 2025: 50.1M, a 14.03% increase year-over-year.
- Taysha Gene Therapies Inc. long term debt for 2025 were 50.1M, a 14.03% increase from 2024.
- Taysha Gene Therapies Inc. long term debt for 2024 were 43.9M, a 8.48% increase from 2023.
- Taysha Gene Therapies Inc. long term debt for 2023 were 40.5M, a 6.69% increase from 2022.
- Taysha Gene Therapies Inc. long term debt for 2022 were 38.0M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Taysha Gene Therapies Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $50 |
| 2024 | $44 |
| 2023 | $41 |
| 2022 | $38 |
Taysha Gene Therapies Inc. Long Term Debt — FAQ
Taysha Gene Therapies Inc. (TSHA) long term debt over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TSHA's long term debt history?
The chart and table above show Taysha Gene Therapies Inc.'s long term debt by year and by quarter, including the growth rate.